FDA-EMA Parallel Scientific Advice Program For Complex Generics Could Add Health Canada

 
• By Derrick Gingery

Preliminary discussions are ongoing about adding Health Canada to the program intended to foster streamlined complex generic approval and increase access.

Canada, USA, EU flags
The FDA-EMA parallel scientific advice program could gain more interest from industry if Health Canada joins the group. • Source: Shutterstock

More from Generics

More from Biosimilars & Generics